IRIDEX CORP Files Amendment on Officer and Director Changes
Ticker: IRIX · Form: 8-K/A · Filed: Nov 26, 2024 · CIK: 1006045
| Field | Detail |
|---|---|
| Company | Iridex Corp (IRIX) |
| Form Type | 8-K/A |
| Filed Date | Nov 26, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $45,000, $20,000, $25,000, $360,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, leadership-change, officer-appointment, director-election
Related Tickers: IRIX
TL;DR
IRIDEX CORP amended its 8-K filing regarding leadership changes. Keep an eye on who's in and who's out.
AI Summary
IRIDEX CORP filed an amendment (8-K/A) on November 26, 2024, to its report originally dated November 7, 2024. The amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing details changes within the company's leadership structure.
Why It Matters
This amendment provides updated information on key personnel changes within IRIDEX CORP, which can impact investor confidence and the company's strategic direction.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings concerning officer and director changes can indicate internal shifts that may affect company strategy and performance.
Key Numbers
- 000-27598 — SEC File Number (Identifies the specific SEC filing for IRIDEX CORP.)
- 77-0210467 — I.R.S. Employer Identification Number (Tax identification number for IRIDEX CORP.)
Key Players & Entities
- IRIDEX CORP (company) — Registrant
- November 7, 2024 (date) — Original report date
- November 26, 2024 (date) — Amendment filing date
- Delaware (location) — State of incorporation
- Mountain View, California (location) — Principal executive offices
FAQ
What specific leadership roles were affected by this amendment?
The amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, but specific names and roles are not detailed in the provided text.
What was the original filing date that this amendment modifies?
The original report date was November 7, 2024.
When was this amendment filed with the SEC?
This amendment (8-K/A) was filed on November 26, 2024.
What is the principal business address of IRIDEX CORP?
The principal executive offices are located at 1212 Terra Bella Avenue, Mountain View, California 94043.
What is the SIC code for IRIDEX CORP?
The Standard Industrial Classification code is 3845, for Electromedical & Electrotherapeutic Apparatus.
Filing Stats: 1,062 words · 4 min read · ~4 pages · Grade level 12.1 · Accepted 2024-11-25 19:16:57
Key Financial Figures
- $0.01 — ch Registered Common Stock, par value $0.01 per share IRIX Nasdaq Capital Marke
- $45,000 — g covenants, including: a lump sum of $45,000, consisting of $20,000 to continue heal
- $20,000 — a lump sum of $45,000, consisting of $20,000 to continue health insurance coverage p
- $25,000 — . Bruce's estimated COBRA premiums, and $25,000 for other intangibles. 100% of Mr. Br
- $360,000 — etain an annualized 2024 base salary of $360,000 and will be eligible to receive an annu
Filing Documents
- irix-20241107.htm (8-K/A) — 54KB
- 0000950170-24-130699.txt ( ) — 176KB
- irix-20241107.xsd (EX-101.SCH) — 30KB
- irix-20241107_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IRIDEX CORPORATION By: /s/ Patrick Mercer Patrick Mercer President and Chief Executive Officer Date: November 25, 2024 - 4 -